+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Egg Donation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 180 Pages
  • April 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6247570
The egg donation market size is expected to increase from USD 3.40 billion in 2025 to USD 3.60 billion in 2026 and reach USD 5.20 billion by 2031, growing at a CAGR of 7.49% over 2026-2031. This report is Segmented by Egg Type (Fresh Donor Eggs, Frozen Donor Eggs), End User (Fertility Clinics, Hospitals, Others), Service Channel (Egg Banks (Banked Frozen Oocytes), Clinic-Recruited Donors (Fresh), Agencies/Matching Services), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Egg Donation Market Trends and Insights

Employer-Funded Fertility Benefits Expand Access and Affordability

California’s Senate Bill 729 obliges group plans with more than 100 employees to cover IVF and donor-egg cycles beginning in 2026, erasing out-of-pocket barriers for nearly 2 million residents. Illinois extended Medicaid fertility benefits in January 2026, and the U.S. Federal Employees Health Benefits program clarified in 2025 that donor-egg procedures qualify for reimbursement. Digital platform Maven Clinic reports employer-sponsored plans now fund majority of its patient volume, underscoring how mandates expand the egg donation market beyond high-income households. Scale favors national clinic chains that can meet sudden demand surges, whereas smaller practices face margin pressure from negotiated reimbursement rates. Comparable legislation under debate in the United Kingdom and Australia signals a broader shift toward insurer-backed fertility coverage.

Vitrification Parity Boosts Adoption of Banked Donor Eggs

Rapid-freeze vitrification prevents ice-crystal damage, yielding survival rates above 90% and live-birth outcomes indistinguishable from those of fresh cycles, according to multiple peer-reviewed studies published between 2024 and 2026. Parity erodes longstanding clinical bias toward fresh eggs and enables egg banks to hold diverse donor inventories, cutting matching times from months to weeks. London Egg Bank reports more than 20,000 frozen eggs ready for overnight shipment across the United Kingdom, while a January 2026 export pact allows Asian Egg Bank to distribute 1,500 frozen eggs to seven countries. Lower donor burden six to ten eggs can be thawed on demand reduces cycle cost and widens access in altruistic-only markets that cap or prohibit monetary compensation.

High Cost and Patchy Reimbursement

A donor-egg IVF cycle costs USD 15,000-25,000 in the United States, USD 10,000-20,000 in Australia, and GBP 8,000-12,000 in the United Kingdom, with donor compensation frequently excluded from insurance. California’s 2026 mandate and Illinois’s Medicaid expansion contrast with Australia’s Medicare exclusion and the U.K.’s rationing of National Health Service coverage, creating affordability cliffs. In Australia, a 1:52 donor-to-recipient ratio forces many patients abroad, while a USD 120 million public fertility program launched in 2024 has recorded only 140 pregnancies and one live birth by early 2026.

Other drivers and restraints analyzed in the detailed report include:
  • Cross-Border Care Concentrates Donor Supply in EU Hubs
  • Clinic-Egg Bank Networks Globalize Donor Access
  • Regulatory Bans or Restrictions in Key Markets
For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Fresh donor eggs held 58.18% of 2025 revenue, and the segment will grow at an 8.13% CAGR through 2031 as recipients favor higher egg yields per retrieval. The egg donation market size for fresh cycles is forecast to reach USD 3.0 billion by 2031, aided by personalized matching in the United States and Spain. Vitrification survival rates above 90% have narrowed the outcome gap, propelling the use of frozen eggs among older recipients and cross-border patients.

Frozen eggs compress timelines from months to weeks, reduce donor burden, and are less exposed to tightening anonymity laws because many were banked before new disclosure mandates. Asian Egg Bank’s partnership to export 1,500 frozen eggs annually demonstrates how banked inventories serve donor-short jurisdictions. Price gaps also matter: frozen cycles in Spain cost EUR 4,500-6,500 versus EUR 6,000-9,000 for fresh, steering value-oriented recipients toward vitrified options.

Complete Report Scope:

  • By Egg Type
    • Fresh Donor Eggs
    • Frozen Donor Eggs
  • By End User
    • Fertility Clinics
    • Hospitals
    • Others
  • By Service Channel
    • Egg Banks (Banked Frozen Oocytes)
    • Clinic‑Recruited Donors (Fresh)
    • Agencies / Matching Services
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Geography Analysis

North America held 36.19% of 2025 revenue, driven by employer mandates, private-equity consolidation, and the world’s most liquid donor-egg supply chain. Colorado’s disclosure law and a 97% applicant rejection rate due to FDA criteria signal a tightening of the labor supply, even as coverage widens. Trait-based compensation differentials, White and Asian donors earning up to USD 100,000 over their lifetimes, are drawing ethical scrutiny. Canada remains constrained by altruistic rules, while Mexico serves as a cost-sensitive destination for U.S. patients.

Europe’s landscape is bifurcated. Spain and the Czech Republic continue to welcome international recipients with anonymous donations and cycle fees below USD 10,000. France’s 2025 anonymity repeal and Belgium’s pending legislation have lengthened waitlists, illustrating how policy can shrink supply faster than recruitment campaigns can respond. The United Kingdom raised donor compensation to GBP 985 in 2024, yet donor numbers stayed flat at around 1,500 annually, leaving thousands on National Health Service waiting lists. Germany, Switzerland, and Austria ban donation, funneling patients into Spain and the Czech Republic.

Asia-Pacific is the fastest-growing territory at an 8.97% CAGR through 2031. Japan reimburses about majority of advanced fertility costs but still forbids commercial donation, sending patients abroad. Australia faces a chronic 1:52 donor-recipient ratio and lags despite a USD 120 million public program that delivered only one birth by early 2026. China’s ban on commercial donation keeps domestic penetration below 1%, although provincial pilots may soften restrictions as population pressure mounts.



List of Companies Covered in this Report:

  • Asian Egg Bank
  • Boston IVF
  • CCRM
  • Create Fertility
  • Cryos International
  • Donor Egg Bank USA
  • Donor Nexus Egg Bank
  • Eugin Group
  • Fairfax EggBank
  • GENNET
  • IVI RMA
  • London Egg Bank
  • Lucina Egg Bank
  • MyEggBank
  • Ovobank / OvobankID
  • Ovoclinic
  • Ovoria
  • Reprofit
  • Shady Grove Fertility
  • Tambre Fertility Clinic
  • TFP Fertility
  • The World Egg & Sperm Bank

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Employer-Funded Fertility Benefits Expand Access and Affordability
4.2.2 Vitrification Parity Boosts Adoption of Banked Donor Eggs
4.2.3 Cross-Border Care Concentrates Donor Supply in EU Hubs
4.2.4 Clinic-Egg Bank Networks Globalize Donor Access
4.2.5 Telehealth-Enabled Donor Matching and Remote Cycles
4.2.6 AI-Enhanced Screening/Selection Improves Outcomes
4.3 Market Restraints
4.3.1 High Cost and Patchy Reimbursement
4.3.2 Regulatory Bans/Restrictions in Key Markets
4.3.3 Erosion Of Anonymity Increases Legal/Compliance Risk
4.3.4 Donor Supply Constraints, Screening Costs, and Ethics
4.4 Value Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter’s Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Egg Type
5.1.1 Fresh Donor Eggs
5.1.2 Frozen Donor Eggs
5.2 By End User
5.2.1 Fertility Clinics
5.2.2 Hospitals
5.2.3 Others
5.3 By Service Channel
5.3.1 Egg Banks (Banked Frozen Oocytes)
5.3.2 Clinic-Recruited Donors (Fresh)
5.3.3 Agencies / Matching Services
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 India
5.4.3.3 Japan
5.4.3.4 South Korea
5.4.3.5 Australia
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
6.3.1 Asian Egg Bank
6.3.2 Boston IVF
6.3.3 CCRM
6.3.4 Create Fertility
6.3.5 Cryos International
6.3.6 Donor Egg Bank USA
6.3.7 Donor Nexus Egg Bank
6.3.8 Eugin Group
6.3.9 Fairfax EggBank
6.3.10 GENNET
6.3.11 IVI RMA
6.3.12 London Egg Bank
6.3.13 Lucina Egg Bank
6.3.14 MyEggBank
6.3.15 Ovobank / OvobankID
6.3.16 Ovoclinic
6.3.17 Ovoria
6.3.18 Reprofit
6.3.19 Shady Grove Fertility
6.3.20 Tambre Fertility Clinic
6.3.21 TFP Fertility
6.3.22 The World Egg & Sperm Bank
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Asian Egg Bank
  • Boston IVF
  • CCRM
  • Create Fertility
  • Cryos International
  • Donor Egg Bank USA
  • Donor Nexus Egg Bank
  • Eugin Group
  • Fairfax EggBank
  • GENNET
  • IVI RMA
  • London Egg Bank
  • Lucina Egg Bank
  • MyEggBank
  • Ovobank / OvobankID
  • Ovoclinic
  • Ovoria
  • Reprofit
  • Shady Grove Fertility
  • Tambre Fertility Clinic
  • TFP Fertility
  • The World Egg & Sperm Bank